サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1422694

バイオマーカー臨床フェーズアウトソーシングサービス市場：バイオマーカータイプ別、治療分野別、エンドユーザー別、世界予測、2024年～2032年

Biomarker Clinical Phase Outsourcing Services Market - By Biomarker Type (Predictive, Prognostic, Surrogate), Therapeutic Area (Oncology, Neurology), End-user (Pharmaceutical & Biotechnology Companies), Global Forecast, 2024-2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 130 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
バイオマーカー臨床フェーズアウトソーシングサービス市場：バイオマーカータイプ別、治療分野別、エンドユーザー別、世界予測、2024年～2032年
出版日: 2023年12月06日
発行: Global Market Insights Inc.
ページ情報: 英文 130 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオマーカー臨床フェーズアウトソーシングサービスの世界市場は2024年から2032年にかけてCAGR 19.2%で成長します。

ヘルスケア産業がオーダーメイドの治療アプローチに軸足を移す中、バイオマーカーは患者の層別化と治療の最適化において極めて重要です。アウトソーシングサービスは、バイオマーカー主導型臨床試験の専門的な需要に対応し、効率性と専門性を確保するために不可欠となっています。個別化医療の可能性が認識されるにつれ、アウトソーシングサービスに対する需要は急増し、市場の拡大を後押しします。

メーカー各社はイノベーションを採用し、臨床試験用製剤を発売することで、業界シェアを強化し、持続的な成長を目指しています。例えば、2023年には、Innovative Trials社が、スポンサーと治験実施施設による治療の迅速化を支援することを目的とした、患者中心の斬新なサービスを発表しました。

バイオマーカー臨床フェーズアウトソーシングサービス業界は、バイオマーカーの種類、治療分野、地域に基づいて分類されます。

予測バイオマーカー分野は2032年までに著しい成長を遂げると思われます。個別化医療が注目されるにつれ、正確な患者層別化の需要が高まり、予測バイオマーカーは臨床試験に不可欠なものとなっています。治療反応を予測するバイオマーカーの役割は、臨床試験の効率と成功率を高める。テーラーメード治療に重点を置く予測バイオマーカー部門は、その優位性を確固たるものにし、市場成長に大きく貢献する主要プレーヤーとして立ちはだかると思われます。

神経分野のバイオマーカー臨床フェーズアウトソーシングサービス市場規模は、2032年までに大幅な拡大が見込まれます。神経疾患の有病率の増加は、この治療領域における研究開発の増加を促し、バイオマーカー主導型臨床試験の需要を高めています。神経学では精密医療が注目されるようになり、こうした臨床試験は専門性が高いため、アウトソーシングサービスが必要となります。神経疾患の診断と治療法の進歩に重点を置く神経学分野は、市場の見通しを形成する中心的な牽引役として台頭してくると思われます。

欧州のバイオマーカー臨床フェーズアウトソーシングサービス業界は、2024年から2032年にかけて著しいCAGRを記録するであろう。同地域の堅調な製薬業界、先進的なヘルスケアインフラ、厳格な規制環境が同市場の優位性に寄与しています。最先端の研究と個別化医療への取り組みにより、欧州はバイオマーカー主導型臨床試験のハブとして位置づけられます。臨床研究機関のネットワークが確立されている欧州は、多額の投資を誘致し、市場拡大の主要な貢献者としての役割を確固たるものにすると思われます。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 バイオマーカー臨床フェーズアウトソーシングサービス市場洞察

  • 業界情勢
  • 業界への影響要因
    • 促進要因
      • バイオマーカー技術の急速な進歩
      • バイオマーカー利用の増加
      • 政府のイニシアティブと資金提供の増加
    • 業界の潜在的リスク＆課題
      • 規制遵守
  • 成長の可能性分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 バイオマーカー臨床フェーズアウトソーシングサービス市場推定・予測：バイオマーカータイプ別、2018年～2032年

  • 主要動向：バイオマーカータイプ別
  • 代替エンドポイント
  • 予測バイオマーカー
  • 予後バイオマーカー
  • 安全性バイオマーカー
  • その他のバイオマーカー

第6章 バイオマーカー臨床フェーズアウトソーシングサービス市場推定・予測：治療領域別、2018年～2032年

  • 主要動向：治療領域別
  • がん領域
  • 神経学
  • 循環器
  • 自己免疫疾患
  • その他の治療領域

第7章 バイオマーカー臨床フェーズアウトソーシングサービス市場推定・予測：エンドユーザー別、2018年～2032年

  • 主要動向：エンドユーザー別
  • 製薬企業
  • バイオテクノロジー企業
  • その他のエンドユーザー

第8章 バイオマーカー臨床フェーズアウトソーシングサービス市場推定・予測：地域別、2018年～2032年

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第9章 企業プロファイル

  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Charles River Laboratories International, Inc.
  • ICON plc
  • Proteome Sciences plc
  • Fujirebio Inc.
  • WuXi AppTec Co., Ltd.
  • NorthEast BioAnalytical Laboratories LLC.
  • Celerion, Inc.
  • GenScript ProBio Co., Ltd.
図表

Data Tables

  • TABLE 1 Market revenue, by biomarker type (2023)
  • TABLE 2 Market revenue, by therapeutic area (2023)
  • TABLE 3 Market revenue, by end-user (2023)
  • TABLE 4 Market share, by region (2023)
  • TABLE 5 Global biomarker clinical phase outsourcing services market size, by region, 2018 - 2023 (USD Million)
  • TABLE 6 Global biomarker clinical phase outsourcing services market size, by region, 2024 - 2032 (USD Million)
  • TABLE 7 Global biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 8 Global biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 9 Global biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 10 Global biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 11 Global biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 12 Global biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 13 Industry impact forces
  • TABLE 14 Surrogate endpoints market, 2018 - 2023 (USD Million)
  • TABLE 15 Surrogate endpoints market, 2024 - 2032 (USD Million)
  • TABLE 16 Predictive biomarker market, 2018 - 2023 (USD Million)
  • TABLE 17 Predictive biomarker market, 2024 - 2032 (USD Million)
  • TABLE 18 Prognostic biomarker market, 2018 - 2023 (USD Million)
  • TABLE 19 Prognostic biomarker market, 2024 - 2032 (USD Million)
  • TABLE 20 Safety biomarker market, 2018 - 2023 (USD Million)
  • TABLE 21 Safety biomarker market, 2024 - 2032 (USD Million)
  • TABLE 22 Other biomarker types market, 2018 - 2023 (USD Million)
  • TABLE 23 Other biomarker types market, 2024 - 2032 (USD Million)
  • TABLE 24 Oncology market, 2018 - 2023 (USD Million)
  • TABLE 25 Oncology market, 2024 - 2032 (USD Million)
  • TABLE 26 Neurology market, 2018 - 2023 (USD Million)
  • TABLE 27 Neurology market, 2024 - 2032 (USD Million)
  • TABLE 28 Cardiology market, 2018 - 2023 (USD Million)
  • TABLE 29 Cardiology market, 2024 - 2032 (USD Million)
  • TABLE 30 Autoimmune diseases market, 2018 - 2023 (USD Million)
  • TABLE 31 Autoimmune diseases market, 2024 - 2032 (USD Million)
  • TABLE 32 Other therapeutic areas market, 2018 - 2023 (USD Million)
  • TABLE 33 Other therapeutic areas market, 2024 - 2032 (USD Million)
  • TABLE 34 Pharmaceutical companies market, 2018 - 2023 (USD Million)
  • TABLE 35 Pharmaceutical companies market, 2024 - 2032 (USD Million)
  • TABLE 36 Biotechnology companies market, 2018 - 2023 (USD Million)
  • TABLE 37 Biotechnology companies market, 2024 - 2032 (USD Million)
  • TABLE 38 Other end-users market, 2018 - 2023 (USD Million)
  • TABLE 39 Other end-users market, 2024 - 2032 (USD Million)
  • TABLE 40 North America biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
  • TABLE 41 North America biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
  • TABLE 42 North America biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 43 North America biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 44 North America biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 45 North America biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 46 North America biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 47 North America biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 48 U.S. biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 49 U.S. biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 50 U.S. biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 51 U.S. biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 52 U.S. biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 53 U.S. biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 54 Canada biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 55 Canada biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 56 Canada biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 57 Canada biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 58 Canada biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 59 Canada biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 60 Europe biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
  • TABLE 61 Europe biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
  • TABLE 62 Europe biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 63 Europe biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 64 Europe biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 65 Europe biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 66 Europe biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 67 Europe biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 68 Germany biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 69 Germany biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 70 Germany biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 71 Germany biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 72 Germany biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 73 Germany biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 74 UK biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 75 UK biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 76 UK biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 77 UK biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 78 UK biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 79 UK biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 80 France biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 81 France biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 82 France biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 83 France biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 84 France biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 85 France biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 86 Spain biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 87 Spain biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 88 Spain biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 89 Spain biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 90 Spain biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 91 Spain biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 92 Italy biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 93 Italy biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 94 Italy biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 95 Italy biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 96 Italy biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 97 Italy biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 98 Rest of Europe biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 99 Rest of Europe biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 100 Rest of Europe biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 101 Rest of Europe biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 102 Rest of Europe biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 103 Rest of Europe biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 104 Asia Pacific biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
  • TABLE 105 Asia Pacific biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
  • TABLE 106 Asia Pacific biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 107 Asia Pacific biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 108 Asia Pacific biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 109 Asia Pacific biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 110 Asia Pacific biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 111 Asia Pacific biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 112 China biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 113 China biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 114 China biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 115 China biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 116 China biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 117 China biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 118 Japan biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 119 Japan biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 120 Japan biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 121 Japan biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 122 Japan biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 123 Japan biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 124 India biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 125 India biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 126 India biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 127 India biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 128 India biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 129 India biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 130 Australia biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 131 Australia biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 132 Australia biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 133 Australia biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 134 Australia biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 135 Australia biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 136 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 137 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 138 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 139 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 140 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 141 Rest of Asia Pacific biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 142 Latin America biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
  • TABLE 143 Latin America biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
  • TABLE 144 Latin America biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 145 Latin America biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 146 Latin America biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 147 Latin America biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 148 Latin America biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 149 Latin America biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 150 Brazil biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 151 Brazil biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 152 Brazil biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 153 Brazil biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 154 Brazil biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 155 Brazil biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 156 Mexico biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 157 Mexico biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 158 Mexico biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 159 Mexico biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 160 Mexico biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 161 Mexico biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 162 Rest of Latin America biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 163 Rest of Latin America biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 164 Rest of Latin America biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 165 Rest of Latin America biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 166 Rest of Latin America biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 167 Rest of Latin America biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 168 Middle East & Africa biomarker clinical phase outsourcing services market size, by country, 2018 - 2023 (USD Million)
  • TABLE 169 Middle East & Africa biomarker clinical phase outsourcing services market size, by country, 2024 - 2032 (USD Million)
  • TABLE 170 Middle East & Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 171 Middle East & Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 172 Middle East & Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 173 Middle East & Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 174 Middle East & Africa biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 175 Middle East & Africa biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 176 South Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 177 South Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 178 South Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 179 South Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 180 South Africa biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 181 South Africa biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 182 Saudi Arabia biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 183 Saudi Arabia biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 184 Saudi Arabia biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 185 Saudi Arabia biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 186 Saudi Arabia biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 187 Saudi Arabia biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)
  • TABLE 188 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2018 - 2023 (USD Million)
  • TABLE 189 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by biomarker type, 2024 - 2032 (USD Million)
  • TABLE 190 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2018 - 2023 (USD Million)
  • TABLE 191 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by therapeutic area, 2024 - 2032 (USD Million)
  • TABLE 192 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by end-user, 2018 - 2023 (USD Million)
  • TABLE 193 Rest of Middle East & Africa biomarker clinical phase outsourcing services market size, by end-user, 2024 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Biomarker clinical phase outsourcing services market industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Industry landscape analysis, 2018 - 2032 (USD Million)
  • FIG 8 Growth potential analysis, by biomarker type
  • FIG 9 Growth potential analysis, by therapeutic area
  • FIG 10 Growth potential analysis, by end-user
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Competitive analysis of major market players, 2022
  • FIG 15 Competitive positioning matrix, 2022
  • FIG 16 Strategic dashboard, 2022
目次
Product Code: 7610

Global Biomarker Clinical Phase Outsourcing Services Market will grow at a 19.2% CAGR from 2024 to 2032, attributed to the escalating focus on personalized medicine. As the healthcare industry pivots towards tailored therapeutic approaches, biomarkers are pivotal in patient stratification and treatment optimization. Outsourcing services have become crucial to meet the specialized demands of biomarker-driven clinical trials, ensuring efficiency and expertise. With the increasing recognition of personalized medicine's potential, the demand for outsourcing services will surge, driving the expansion of the market.

Manufacturers are adopting innovations and launching clinical trial formulations, thus bolstering their industry share and positioning themselves for sustained growth. For instance, in 2023, Innovative Trials introduced a novel patient-centric service aimed at assisting sponsors and sites in expediting the advancement of their therapies.

The biomarker clinical phase outsourcing services industry is classified based on biomarker type, therapeutic area, and region.

The predictive biomarker segment will garner remarkable gains by 2032. As personalized medicine gains prominence, the demand for precise patient stratification intensifies, making predictive biomarkers indispensable in clinical trials. Their role in forecasting treatment responses enhances trial efficiency and success rates. With a focus on tailored therapies, the predictive biomarker segment will stand as a key player, solidifying its dominance and contributing significantly to the market growth.

The biomarker clinical phase outsourcing services market size from the neurology segment will witness a substantial upswing by 2032. The growing prevalence of neurological disorders prompts increased research and development in this therapeutic area, elevating the demand for biomarker-driven clinical trials. As precision medicine gains prominence in neurology, the specialized nature of these trials necessitates outsourcing services. With a focus on advancing diagnostics and therapeutics for neurological conditions, the neurology segment will emerge as a central driver, shaping the market outlook.

Europe biomarker clinical phase outsourcing services industry will register a significant CAGR from 2024 to 2032. The region's robust pharmaceutical industry, advanced healthcare infrastructure, and stringent regulatory environment contribute to its prominence. The commitment to cutting-edge research and a focus on personalized medicine will position Europe as a hub for biomarker-driven clinical trials. With a well-established network of clinical research organizations, Europe will attract substantial investments, solidifying its role as the primary contributor to market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Biomarker clinical phase outsourcing services industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Biomarker type trends
    • 2.1.4 Therapeutic area trends
    • 2.1.5 End-user trends

Chapter 3 Biomarker Clinical Phase Outsourcing Services Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rapid advancements in biomarker technology
      • 3.2.1.2 Increasing use of biomarkers
      • 3.2.1.3 Rising government initiatives and funding
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Regulatory compliance
  • 3.3 Growth potential analysis
    • 3.3.1 By biomarker type
    • 3.3.2 By therapeutic area
    • 3.3.3 By end-user
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Biomarker Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by biomarker type
  • 5.2 Surrogate endpoints
  • 5.3 Predictive biomarker
  • 5.4 Prognostic biomarker
  • 5.5 Safety biomarker
  • 5.6 Other biomarker types

Chapter 6 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Therapeutic Area, 2018-2032 (USD Million)

  • 6.1 Key trends, by therapeutic area
  • 6.2 Oncology
  • 6.3 Neurology
  • 6.4 Cardiology
  • 6.5 Autoimmune diseases
  • 6.6 Other therapeutic areas

Chapter 7 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

  • 7.1 Key trends, by end-user
  • 7.2 Pharmaceutical companies
  • 7.3 Biotechnology companies
  • 7.4 Other end-users

Chapter 8 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Laboratory Corporation of America Holdings
  • 9.2 Parexel International Corporation
  • 9.3 Charles River Laboratories International, Inc.
  • 9.4 ICON plc
  • 9.5 Proteome Sciences plc
  • 9.6 Fujirebio Inc.
  • 9.7 WuXi AppTec Co., Ltd.
  • 9.8 NorthEast BioAnalytical Laboratories LLC.
  • 9.9 Celerion, Inc.
  • 9.10 GenScript ProBio Co., Ltd.